Warning! GuruFocus detected
5 Severe warning signs
with BGA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
BioNeutra Global Corp
NAICS : 311230
SIC : 1051
ISIN : CA09073L1067
Compare
Compare
Traded in other countries / regions
BGA.CanadaBGACF.USA IPO Date
1999-09-28Description
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -0.61 | |||||
| Debt-to-Equity | -0.92 | |||||
| Debt-to-EBITDA | 7.82 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -1.86 | |||||
| Beneish M-Score | -2.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -22.1 | |||||
| 3-Year EBITDA Growth Rate | 37 | |||||
| 3-Year EPS without NRI Growth Rate | 13 | |||||
| 3-Year FCF Growth Rate | -21.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.02 | |||||
| 9-Day RSI | 44.14 | |||||
| 14-Day RSI | 46.29 | |||||
| 6-1 Month Momentum % | -40 | |||||
| 12-1 Month Momentum % | -72.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.17 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 209.55 | |||||
| Days Sales Outstanding | 33.79 | |||||
| Days Payable | 828.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -43.78 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.85 | |||||
| Operating Margin % | -3.16 | |||||
| Net Margin % | -5.62 | |||||
| FCF Margin % | -4.66 | |||||
| ROA % | -4.06 | |||||
| ROIC % | -3.51 | |||||
| 3-Year ROIIC % | -63.89 | |||||
| ROC (Joel Greenblatt) % | 2.08 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.12 | |||||
| EV-to-EBIT | 46.25 | |||||
| EV-to-EBITDA | 8.44 | |||||
| EV-to-Revenue | 0.75 | |||||
| EV-to-FCF | -16.09 | |||||
| Price-to-GF-Value | 0.6 | |||||
| Price-to-Median-PS-Value | 0.27 | |||||
| Earnings Yield (Greenblatt) % | 2.16 | |||||
| FCF Yield % | -36.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioNeutra Global Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 10.859 | ||
| EPS (TTM) (C$) | -0.03 | ||
| Beta | 1.68 | ||
| 3-Year Sharpe Ratio | 0.52 | ||
| 3-Year Sortino Ratio | 1.95 | ||
| Volatility % | 70.86 | ||
| 14-Day RSI | 46.29 | ||
| 14-Day ATR (C$) | 0.000332 | ||
| 20-Day SMA (C$) | 0.03 | ||
| 12-1 Month Momentum % | -72.73 | ||
| 52-Week Range (C$) | 0.03 - 0.14 | ||
| Shares Outstanding (Mil) | 46.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioNeutra Global Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioNeutra Global Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioNeutra Global Corp Frequently Asked Questions
What is BioNeutra Global Corp(TSXV:BGA)'s stock price today?
The current price of TSXV:BGA is C$0.03. The 52 week high of TSXV:BGA is C$0.14 and 52 week low is C$0.03.
When is next earnings date of BioNeutra Global Corp(TSXV:BGA)?
The next earnings date of BioNeutra Global Corp(TSXV:BGA) is .
Does BioNeutra Global Corp(TSXV:BGA) pay dividends? If so, how much?
BioNeutra Global Corp(TSXV:BGA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers